A Brain Cancer Vaccine?

A new vaccine is designed to help train immune cells to target a mutation unique to brain tumors
A new vaccine is designed to help train immune cells to target a mutation unique to brain tumors

A new article published in the journal Nature is reporting promising results from a landmark Phase 1 human trial testing a novel vaccine designed to help a patient’s immune system better target brain tumors. The data suggests the experimental vaccine is safe and stimulates a significant immune response that slows tumor progression. A larger Phase 2 trial is currently being planned. read more